SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-19-009128
Filing Date
2019-05-14
Accepted
2019-05-14 17:28:03
Documents
65
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 1015040
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 15967
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 15985
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 6905
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6873
  Complete submission text file 0001140361-19-009128.txt   4983070

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pdsb-20190331.xml EX-101.INS 732697
7 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20190331.xsd EX-101.SCH 48302
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pdsb-20190331_cal.xml EX-101.CAL 45161
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pdsb-20190331_def.xml EX-101.DEF 225974
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20190331_lab.xml EX-101.LAB 661935
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20190331_pre.xml EX-101.PRE 392259
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 19824030
SIC: 2834 Pharmaceutical Preparations